Alembic galloped 8.90% to Rs 33.65,on 7th Nov-08, at 13:09 IST on BSE, on proposal of buy plan.
The stock hit a high of Rs 36 and a low of Rs 29.50 so far during the day. The stock has a 52-week high of Rs 107.30 on 17 December 2007 and a 52-week low of Rs 24.75 on 24 October 2008.
The company's current equity is Rs 27.69 crore. Face value per share is Rs 2.
The current price of Rs 33.65 discounts the company's Q2 September 2008 annualized EPS of Rs 4.35, by a PE multiple of 7.74.
Alembic's board will meet on 14 November 2008 to consider buyback of own shares. The company made this announcement during trading hours today, 7 November 2008.
Alembic's net profit fell 67% to Rs 15.04 crore on 13.1% increase in net sales to Rs 344.68 crore in Q2 September 2008 over Q2 September 2007.
The company is engaged in manufacturing and selling bulk drugs and pharmaceutical formulations in human and animal healthcare. It manufactures and markets antibiotics and antibacterial, cough and cold remedies, analgesic and anti-inflammatory medications, nutraceuticals and anti-diabetics.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment